Tumorprogression

Tumor progression is a phenomenon where a pre-formed tumor acquires successive morphological and molecular changes to become more aggressive and malignant. It begins when cancers originate from somatic mutations in a single cell, and over time, the mutant cell's progeny continue to proliferate and pass mutations to daughter cells. As the genome becomes increasingly unstable, more mutations accumulate, driving the tumor toward greater malignancy.

In chronic myelogenous leukemia, the Philadelphia chromosome forms through a reciprocal translocation where parts of chromosomes 22 and 9 swap places. This creates a fusion protein called BCR-ABL1 that increases cell division rates, allows cells to escape terminal differentiation, and prevents apoptosis. These effects cause abnormal cells to accumulate, driving tumor progression.

As tumors progress, cancer cells stimulate the formation of new blood vessels through angiogenesis. These vessels supply oxygen, nutrients, and growth factors that enable rapid cancer cell growth and proliferation. Additionally, the new blood vessels facilitate cancer cell dissemination to distant body parts, enabling metastasis and secondary tumor formation.

The parallel progression model shows that breast cancer cells from a primary tumor as small as 1-4 millimeters can disseminate to distant organs and seed new tumors. Over 6-12 years, these seeds develop into secondary tumors in parallel, each acquiring unique mutations at faster rates. This random mutation accumulation increases resistance to cancer treatment, threatening patient survival.

Colon cancer progression involves sequential mutations in specific genes. Early mutations in the APC gene cause a small growth called a polyp. Further mutations in K-ras and p53 genes transform the benign polyp into a malignant tumor. At advanced stages, mutations in DCC and related genes contribute to tissue invasion and metastasis.

Cancer cells overcome normal cell cycle regulation by skipping the resting G0 phase and progressing directly from the M phase to the G1 phase, allowing continuous division without terminal differentiation or apoptosis. They also overcome contact inhibition, a property that normally stops cell division when cells contact each other. This enables cancer cells to pile up and form tumor masses.

Three important gene groups drive cancer progression. The first includes genes involved in cell growth and survival. The second comprises genes maintaining genetic stability, such as DNA repair enzymes. The third group involves genes controlling tissue invasion and metastasis, including those encoding cell adhesion proteins, proteolytic enzymes, and angiogenesis factors.